Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents

Highlights • HNSCC survival was poorer among cases in Brazil than in the US and Europe. • HPV+/p16+ OPSCC predicted lower mortality in all 3 regions (US, Europe, Brazil). • HPV was not prognostic among non-OP HNSCC (OC, larynx, and HP). • Effect of HPV/p16 was significantly different in OPSCC &...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2016-11, Vol.62, p.20-27
Hauptverfasser: D’Souza, Gypsyamber, Anantharaman, Devasena, Gheit, Tarik, Abedi-Ardekani, Behnoush, Beachler, Daniel C, Conway, David I, Olshan, Andrew F, Wunsch-Filho, Victor, Toporcov, Tatiana N, Ahrens, Wolfgang, Wisniewski, Kathy, Merletti, Franco, Boccia, Stefania, Tajara, Eloiza H, Zevallos, Jose P, Levi, José Eduardo, Weissler, Mark C, Wright, Sylvia, Scelo, Ghislaine, Mazul, Angela L, Tommasino, Massimo, Cadoni, Gabriella, Brennan, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • HNSCC survival was poorer among cases in Brazil than in the US and Europe. • HPV+/p16+ OPSCC predicted lower mortality in all 3 regions (US, Europe, Brazil). • HPV was not prognostic among non-OP HNSCC (OC, larynx, and HP). • Effect of HPV/p16 was significantly different in OPSCC & non-OP HNSCC.
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2016.09.005